Talaporfin (INN, also known as aspartyl chlorin, mono-L-aspartyl chlorin e6, NPe6, or LS11) is a chlorin based photosensitizer used in photodynamic therapy...
4 KB (167 words) - 01:18, 11 February 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
31 KB (2,908 words) - 06:38, 22 September 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
37 KB (3,397 words) - 01:51, 12 November 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
19 KB (1,757 words) - 09:15, 29 October 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
61 KB (6,086 words) - 22:34, 7 November 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
31 KB (2,832 words) - 13:30, 20 September 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
26 KB (2,647 words) - 17:55, 13 October 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
20 KB (1,870 words) - 00:52, 30 October 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
18 KB (1,637 words) - 04:59, 12 November 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
15 KB (1,090 words) - 15:26, 1 November 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
15 KB (1,437 words) - 03:54, 17 October 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
18 KB (1,559 words) - 14:08, 31 October 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
20 KB (1,915 words) - 00:12, 31 March 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
9 KB (716 words) - 15:15, 27 October 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
26 KB (2,420 words) - 17:03, 13 November 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
5 KB (324 words) - 12:07, 20 July 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
31 KB (2,796 words) - 07:50, 10 August 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
33 KB (2,959 words) - 02:09, 16 July 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
4 KB (128 words) - 11:38, 22 April 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
4 KB (411 words) - 21:05, 6 May 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
9 KB (595 words) - 06:22, 6 October 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
24 KB (2,272 words) - 08:01, 11 November 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
59 KB (6,440 words) - 17:52, 13 November 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
24 KB (2,132 words) - 11:10, 7 September 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
19 KB (1,553 words) - 19:42, 17 May 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
39 KB (3,990 words) - 18:36, 16 October 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
39 KB (3,864 words) - 22:43, 20 September 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
49 KB (4,454 words) - 18:07, 8 August 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
16 KB (1,041 words) - 22:27, 20 September 2024
Methyl aminolevulinate Padeliporfin Porphyrin derivatives (Porfimer sodium Talaporfin Temoporfin Verteporfin) Other #WHO-EM ‡Withdrawn from market Clinical...
17 KB (1,321 words) - 00:56, 12 September 2024